109 related articles for article (PubMed ID: 35143037)
1. A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer.
Wang Z; Zhang Y; Jiang C; Gong B
Clin Transl Oncol; 2022 Jul; 24(7):1381-1394. PubMed ID: 35143037
[TBL] [Abstract][Full Text] [Related]
2. A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence.
Xing Q; Liu S; Luan J; Wang Y; Ma L
Pathol Res Pract; 2021 Sep; 225():153587. PubMed ID: 34419719
[TBL] [Abstract][Full Text] [Related]
3. Identification of an immune-related RNA-binding protein signature to predict survival and targeted therapy responses in liver cancer.
Yang S; Lin S; Liu K; Liu Y; Xu P; Zheng Y; Deng Y; Zhang D; Zhai Z; Li N; Ren X; Dai Z; Kang H
Genomics; 2021 Mar; 113(2):795-804. PubMed ID: 33524497
[TBL] [Abstract][Full Text] [Related]
4. RNA Binding Protein-Based Model for Prognostic Prediction of Colorectal Cancer.
Li T; Hui W; Halike H; Gao F
Technol Cancer Res Treat; 2021; 20():15330338211019504. PubMed ID: 34080453
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Jin Y; Qin X
DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer.
Gao L; Meng J; Zhang Y; Gu J; Han Z; Wang X; Gao S
Genomics; 2020 Nov; 112(6):4980-4992. PubMed ID: 32882325
[TBL] [Abstract][Full Text] [Related]
7. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
Chen F; Wang Q; Zhou Y
BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer.
He C; Huang F; Zhang K; Wei J; Hu K; Liang M
J Ovarian Res; 2021 Feb; 14(1):27. PubMed ID: 33550985
[TBL] [Abstract][Full Text] [Related]
10. A Novel Model of Tumor-Infiltrating B Lymphocyte Specific RNA-Binding Protein-Related Genes With Potential Prognostic Value and Therapeutic Targets in Multiple Myeloma.
Zhang J; He P; Wang X; Wei S; Ma L; Zhao J
Front Genet; 2021; 12():778715. PubMed ID: 34976013
[No Abstract] [Full Text] [Related]
11. Complementary analysis of proteome-wide proteomics reveals changes in RNA binding protein-profiles during prostate cancer progression.
Aikio E; Koivukoski S; Kallio E; Sadeesh N; Niskanen EA; Latonen L
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1886. PubMed ID: 37591798
[TBL] [Abstract][Full Text] [Related]
12. Immune-Related RNA-Binding Protein-Based Signature With Predictive and Prognostic Implications in Patients With Lung Adenocarcinoma.
Xu L; Li W; Yang T; Hu S; Zou Q; Jiao J; Jiang N; Zhang Y
Front Mol Biosci; 2022; 9():807622. PubMed ID: 35647031
[No Abstract] [Full Text] [Related]
13. A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
Zhu M; Cai J; Wu Y; Wu X; Feng L; Yin Z
Med Sci Monit; 2021 Jan; 27():e928195. PubMed ID: 33471782
[TBL] [Abstract][Full Text] [Related]
14. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.
Chen Q; Li ZL; Fu SQ; Wang SY; Liu YT; Ma M; Yang XR; Xie WJ; Gong BB; Sun T
Aging (Albany NY); 2021 Jan; 13(3):3926-3944. PubMed ID: 33461173
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma.
Tian J; Ma C; Yang L; Sun Y; Zhang Y
Front Genet; 2021; 12():723796. PubMed ID: 34531901
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Characterization of RNA-Binding Proteins in Colon Adenocarcinoma Identifies a Novel Prognostic Signature for Predicting Clinical Outcomes and Immunotherapy Responses Based on Machine Learning.
Miao Y; Yuan Q; Wang C; Feng X; Ren J; Wang C
Comb Chem High Throughput Screen; 2023; 26(1):163-182. PubMed ID: 35379120
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Sun D; Yang KS; Chen JL; Wang ZB
World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
[TBL] [Abstract][Full Text] [Related]
18. Identification of Prognosis-Related RNA-Binding Proteins to Reveal the Role of RNA-Binding Proteins in the Progression and Prognosis of Colon Cancer.
Ding Y; Fang L; Yang XP; Zou Q
Int J Gen Med; 2021; 14():6795-6805. PubMed ID: 34703285
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.
Chen Z; Wu H; Yang H; Fan Y; Zhao S; Zhang M
Cancer Med; 2021 Oct; 10(20):7418-7439. PubMed ID: 34482648
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of the functions and prognostic values of RNA-binding proteins in neuroblastoma.
Yang J; Zhou J; Li C; Wang S
PLoS One; 2021; 16(12):e0260876. PubMed ID: 34879089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
